Cheerio to the big breakfast cereal brands

Is Big Cereal going the way of Big Pharma?

I ask because there seems to be some evidence of sagging innovation in the all-important breakfast cereal market.

Consider this article in Fortune that extols the relentless efforts by General Mills, the maker of Cheerios, Wheaties and Lucky Charms, to fatten its margins by cutting costs. It cites General Mills’ elimination of letter shapes in its Hot’n'Spicy Chex Mix, which has provoked this online protest petition.

Then consider this chart of branded cereal innovation in the 20th century produced by Geek Out New York. It shows a burst of cereal creativity in the mid-century that brought us such great names as Rice Krispies (1928), Cheerios (1941) and Special K (1956). There is a history of Cheerios here.

Then consider this article in the Wall Street Journal reporting that supermarket customers in the US are increasingly turning to white label substitutes for famous brands, a trend that affects companies such as General Mills and Procter and Gamble.

Finally, consider the Gapper family’s kitchen cupboard. OK, you cannot so I will give you a clue. Taking a look this morning, I noted packets of both Cheerios and Honey Nut Cheerios but also their white label equivalents from Trader Joe’s. There was also some Bob’s Red Mill Old Country Style Muesli.

In pharmaceutical terms, branded cereals such as Cheerios are the blockbusters of the cereal industry, while the white label versions are the generics. I would call Bob’s Red Mill Old Country Style Muesli, which is pricey stuff, the equivalent of a biotech drug.

The Big Cereal innovation pipeline seems to be running dry just as it has done in the pharma industry, leaving companies such as General Mills to cut costs in an effort to see off generics. Meanwhile, small producers such as Bob’s Red Mill are taking the high end of the market.

If I were a shareholder of General Mills, I would be worried. The industry is bifurcating between low-cost generics and high-priced speciality items, with the established mass products coming under strain in the middle. The cereal brands do not even have patent protection on their side.

It is definitely something to chew over.

Business blog

Strategy & managing

About this blog Blog guide
This blog is mainly about business and strategy and how and why people who run companies take the decisions that they do.

Most of the time, John Gapper is in New York and Andrew Hill is in London. We occasionally debate business issues between us, but your comments and criticism are welcome.




To comment, please register for free with FT.com and read our policy on submitting comments.

All posts are published in UK time.

Contact andrew.hill@ft.com or john.gapper@ft.com about the Business blog.

See the full list of FT blogs.

About John and Andrew

John Gapper is an associate editor and the chief business commentator of the FT. He has worked for the FT since 1987, covering labour relations, banking and the media. He is co-author, with Nicholas Denton, of All That Glitters, an account of the collapse of Barings in 1995.

Andrew Hill is an associate editor and the management editor of the FT. He is a former City editor, financial editor, comment and analysis editor, New York bureau chief, foreign news editor and correspondent in Brussels and Milan.

Archive

« Oct Dec »November 2008
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930